Cadmium and silver complexes of a pyridine containing ligand: syntheses, structural studies, biological activity and docking studies
Azza A. Hassoon,Stacey J. Smith,Roger G. Harrison
DOI: https://doi.org/10.1039/d4ra05305b
IF: 4.036
2024-10-09
RSC Advances
Abstract:The current study aimed to synthesize seven new metal coordination complexes ( Q1–Q7 ) with potential biomedical applications. Novel mononuclear, polynuclear and mixed-ligand coordination compounds of the elements, cadmium( II ) and silver( I ) derived from a pyridine containing ligand (2,4,6-tris-(2-pyridyl)-1,3,5-triazine ( TPT )) have been synthesized successfully with the general formulae [Cd( TPT )Cl 6 ]·H 2 O and [Ag x ( TPT ) y (L) 2 (ClO 4 )](ClO 4 ) z ( x = 1,2,3, y = 1,2,3, L = PPh 3 or phen, z = 1,2). The structural features were fully characterized using various spectroscopic techniques, such as infrared, ultraviolet-visible spectroscopy, 1D and 2D-NMR ( 1 H, 13 C, 31 P, 1 H– 1 H COSY and 1 H– 13 C HSQCAD), CHN analysis, molar conductance ( Λ ), thermogravimetric analysis (TGA), and powder X-ray diffraction analysis. The structure of complex Q6 was also confirmed by single-crystal X-ray analysis. The luminescence and electrochemical properties of complexes, in solution, have been studied. X-ray crystallographic determination of the [Ag( TPT )(PPh 3 ) 2 ]ClO 4 ·EtOH ( Q6 ) complex shows that the Ag + cation is bonded to one tridentate TPT ligand through NNN set of donor atoms and two triphenylphosphine ligands, giving the Ag + a distorted trigonal bipyramidal geometry. X-ray powder diffraction analysis showed that metal complexes Q3 , Q6 and Q7 display crystalline peaks. The complexes were evaluated for their in vitro antibacterial efficacy against various bacterial and fungal species. The in vitro efficacy against the MCF-7 human breast cancer cell line was assessed to determine the anticancer activities. The tri-nuclear silver complex Q3 shows great potential as a therapeutic candidate for treating breast cancer, since it exhibits a half-maximal inhibition concentration (IC 50 ) of 13.45 ± 0.9 μM. Molecular docking simulations were also carried out to evaluate the interaction strength and properties of the metal complexes with selected cancer and bacteria relevant proteins namely cyclin-dependent kinase 2 (CDK2), cyclin-dependent kinase 6 (CDK6), signal transducer and activator of transcription 3 (STAT3), and beta-lactamases from Escherichia coli and Staphylococcus aureus .
chemistry, multidisciplinary